{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,20]],"date-time":"2026-01-20T07:35:20Z","timestamp":1768894520141,"version":"3.49.0"},"reference-count":23,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"8","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:sec>\n            <jats:title>Introduction<\/jats:title>\n            <jats:p>There is a persistent controversy regarding the benefit and timing of angiography in patients with stable coronary artery disease (CAD). With this meta-analysis of randomized controlled trials (RCTs) the advantages of initial invasive strategy and medical therapy compared with only medical therapy.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>We conducted a literature search of the following databases Pubmed\/MEDLINE, Cochrane Library and Embase. Data was collected from all the RCTs that compared early invasive approach with medical therapy alone in treating stable CAD which was conducted by two independent authors. Primary outcomes were all-cause mortality and myocardial infarction (MI), while the secondary outcomes included major adverse cardiovascular events (MACE), cardiovascular mortality, cardiovascular hospitalization, hospitalization due to unstable angina and revascularization events. The Mantel\u2013Haenszel random-effects model was used to estimate risk ratios (RRs) and 95% confidence intervals (CIs).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>We included 15 RCTs (13 916 patients, mean age 63.1, 78.9% men). The early invasive strategy, compared with medical therapy alone, did not reveal a significant reduction in the incidence of all-cause mortality (RR, 0.94; 95% CI, 0.84\u20131.05, <jats:italic toggle=\"yes\">P<\/jats:italic> = 0.30) or MI (RR, 0.93; 95% CI, 0.79\u20131.10, <jats:italic toggle=\"yes\">P<\/jats:italic> = 0.42). Furthermore, the early invasive strategy did not reduce the incidence of cardiovascular mortality, cardiovascular hospitalization or the revascularization rate compared with medical therapy alone (<jats:italic toggle=\"yes\">P<\/jats:italic> &gt; 0.05). However, the incidence of MACE and hospitalization due to unstable angina were lower in patients treated with early invasive strategy (RR, 0.79; 95% CI, 0.63\u20130.99, <jats:italic toggle=\"yes\">P<\/jats:italic> = 0.04), and (RR, 0.46; 95% CI, 0.32\u20130.67, <jats:italic toggle=\"yes\">P<\/jats:italic> &lt; 0.0001), respectively.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions<\/jats:title>\n            <jats:p>Early invasive strategy with medical therapy did not reduce the incidence of all-cause mortality and MI when compared with medical therapy alone among patients with stable CAD with significant stenosis. However, there was a significant reduction in the incidence of MACE and hospitalization due to unstable angina in the early invasive group.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/mca.0000000000001030","type":"journal-article","created":{"date-parts":[[2021,4,7]],"date-time":"2021-04-07T16:16:28Z","timestamp":1617812188000},"page":"721-729","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":2,"title":["Initial optimal medical therapy with or without invasive strategy for stable coronary disease: a meta-analysis and systematic review"],"prefix":"10.1097","volume":"32","author":[{"given":"Mahmoud","family":"Barbarawi","sequence":"first","affiliation":[{"name":"Department of Cardiology, University of Connecticut, Farmington, Connecticut"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ahmad","family":"Alabdouh","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Saint Agnes Hospital, Baltimore, Maryland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Owais","family":"Barbarawi","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Mutah University, Al-Karak, Jordan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Harini","family":"Lakshman","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Hurley Medical Center\/Michigan State University, Flint, Michigan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mariam","family":"Alkasasbeh","sequence":"additional","affiliation":[{"name":"Department of Health Administration, Western Connecticut State University, Danbury, Connecticut"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Muad","family":"Khallad","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Ross University School of Medicine, Miramar, Florida"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qais","family":"Radaideh","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, University of Iowa Hospitals and Clinics, Iowa, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2021,3,16]]},"reference":[{"key":"R1-20250729","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1093\/eurheartj\/ehz425","article-title":"2019 ESC guidelines for the diagnosis and management of chronic coronary syndromes.","volume":"41","author":"Knuuti","year":"2020","journal-title":"Eur Heart J"},{"key":"R2-20250729","doi-asserted-by":"crossref","first-page":"2564","DOI":"10.1016\/j.jacc.2012.07.012","article-title":"2012 ACCF\/AHA\/ACP\/AATS\/PCNA\/SCAI\/STS guideline for the diagnosis and management of patients with stable ischemic heart disease: executive summary: a Report of the American College of Cardiology Foundation\/American Heart Association Task Force on Practice Guidelines, and the American College of Physicians, American Association for Thoracic Surgery, Preventive Cardiovascular Nurses Association, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons.","volume":"60","author":"Fihn","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"R3-20250729","first-page":"185","article-title":"Meta-analysis of optimal timing of coronary intervention in non-ST-elevation acute coronary syndrome.","volume":"95","author":"Barbarawi","year":"2020","journal-title":"Catheter Cardiovasc Interv"},{"key":"R4-20250729","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1093\/eurheartj\/ehx393","article-title":"2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: The Task Force for the management of acute myocardial infarction in patients presenting with ST-segment elevation of the European Society of Cardiology (ESC).","volume":"39","author":"Ibanez","year":"2018","journal-title":"Eur Heart J"},{"key":"R5-20250729","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1056\/NEJMoa070829","article-title":"Optimal medical therapy with or without PCI for stable coronary disease.","volume":"356","author":"Boden","year":"2007","journal-title":"N Engl J Med"},{"key":"R6-20250729","doi-asserted-by":"crossref","first-page":"2212","DOI":"10.1016\/j.jacc.2017.02.001","article-title":"ACC\/AATS\/AHA\/ASE\/ASNC\/SCAI\/SCCT\/STS 2017 appropriate use criteria for coronary revascularization in patients with stable ischemic heart disease: a Report of the American College of Cardiology Appropriate Use Criteria Task Force, American Association for Thoracic Surgery, American Heart Association, American Society of Echocardiography, American Society of Nuclear Cardiology, Society for Cardiovascular Angiography and Interventions, Society of Cardiovascular Computed Tomography, and Society of Thoracic Surgeons.","volume":"69","author":"Patel","year":"2017","journal-title":"J Am Coll Cardiol"},{"key":"R7-20250729","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1056\/NEJMoa1803538","article-title":"Five-year outcomes with PCI guided by fractional flow reserve.","volume":"379","author":"Xaplanteris","year":"2018","journal-title":"N Engl J Med"},{"key":"R8-20250729","doi-asserted-by":"crossref","first-page":"2900","DOI":"10.1161\/01.CIR.0000072790.23090.41","article-title":"Comparison of the short-term survival benefit associated with revascularization compared with medical therapy in patients with no prior coronary artery disease undergoing stress myocardial perfusion single photon emission computed tomography.","volume":"107","author":"Hachamovitch","year":"2003","journal-title":"Circulation"},{"key":"R9-20250729","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1056\/NEJMoa1915922","article-title":"Initial invasive or conservative strategy for stable coronary disease.","volume":"382","author":"Maron","year":"2020","journal-title":"N Engl J Med"},{"key":"R10-20250729","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/j.jclinepi.2009.06.006","article-title":"The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration.","volume":"62","author":"Liberati","year":"2009","journal-title":"J Clin Epidemiol"},{"key":"R11-20250729","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1016\/S0735-1097(97)00097-1","article-title":"Percutaneous transluminal coronary angioplasty versus medical therapy for stable angina pectoris: outcomes for patients with double-vessel versus single-vessel coronary artery disease in a Veterans Affairs Cooperative randomized trial. Veterans affairs ACME investigators.","volume":"29","author":"Folland","year":"1997","journal-title":"J Am Coll Cardiol"},{"key":"R12-20250729","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1161\/01.CIR.0000121360.31954.1F","article-title":"Percutaneous coronary angioplasty compared with exercise training in patients with stable coronary artery disease: a randomized trial.","volume":"109","author":"Hambrecht","year":"2004","journal-title":"Circulation"},{"key":"R13-20250729","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1056\/NEJM199201023260102","article-title":"A comparison of angioplasty with medical therapy in the treatment of single-vessel coronary artery disease. Veterans affairs ACME investigators.","volume":"326","author":"Parisi","year":"1992","journal-title":"N Engl J Med"},{"key":"R14-20250729","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1001\/jama.289.9.1117","article-title":"Outcome of elderly patients with chronic symptomatic coronary artery disease with an invasive vs optimized medical treatment strategy: one-year results of the randomized TIME trial.","volume":"289","author":"Pfisterer","year":"2003","journal-title":"JAMA"},{"key":"R15-20250729","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1056\/NEJM199907083410202","article-title":"Aggressive lipid-lowering therapy compared with angioplasty in stable coronary artery disease. Atorvastatin versus revascularization treatment investigators.","volume":"341","author":"Pitt","year":"1999","journal-title":"N Engl J Med"},{"key":"R16-20250729","doi-asserted-by":"crossref","first-page":"2037","DOI":"10.1161\/01.CIR.95.8.2037","article-title":"Asymptomatic cardiac ischemia pilot (ACIP) study two-year follow-up: outcomes of patients randomized to initial strategies of medical therapy versus revascularization.","volume":"95","author":"Davies","year":"1997","journal-title":"Circulation"},{"key":"R17-20250729","doi-asserted-by":"crossref","first-page":"2503","DOI":"10.1056\/NEJMoa0805796","article-title":"A randomized trial of therapies for type 2 diabetes and coronary artery disease.","volume":"360","author":"Frye","year":"2009","journal-title":"New Engl J Med"},{"key":"R18-20250729","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1016\/S0735-1097(03)00951-3","article-title":"Seven-year outcome in the RITA-2 trial: coronary angioplasty versus medical therapy.","volume":"42","author":"Henderson","year":"2003","journal-title":"J Am Coll Cardiol"},{"key":"R19-20250729","doi-asserted-by":"crossref","first-page":"1600","DOI":"10.1016\/0735-1097(95)00384-3","article-title":"The medicine, angioplasty or surgery study (MASS): a prospective, randomized trial of medical therapy, balloon angioplasty or bypass surgery for single proximal left anterior descending artery stenoses.","volume":"26","author":"Hueb","year":"1995","journal-title":"J Am Coll Cardiol"},{"key":"R20-20250729","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1161\/CIRCULATIONAHA.109.911669","article-title":"Ten-year follow-up survival of the medicine, angioplasty, or surgery study (MASS II): a randomized controlled clinical trial of 3 therapeutic strategies for multivessel coronary artery disease.","volume":"122","author":"Hueb","year":"2010","journal-title":"Circulation"},{"key":"R21-20250729","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/j.jcin.2008.08.002","article-title":"Percutaneous coronary intervention plus medical therapy reduces the incidence of acute coronary syndrome more effectively than initial medical therapy only among patients with low-risk coronary artery disease a randomized, comparative, multicenter study.","volume":"1","author":"Nishigaki","year":"2008","journal-title":"JACC Cardiovasc Interv"},{"key":"R22-20250729","doi-asserted-by":"crossref","first-page":"3182","DOI":"10.1093\/eurheartj\/ehv452","article-title":"Deferral vs. performance of percutaneous coronary intervention of functionally non-significant coronary stenosis: 15-year follow-up of the DEFER trial.","volume":"36","author":"Zimmermann","year":"2015","journal-title":"Eur Heart J"},{"key":"R23-20250729","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/j.jacc.2009.03.063","article-title":"Prognostic significance of periprocedural versus spontaneously occurring myocardial infarction after percutaneous coronary intervention in patients with acute coronary syndromes: an analysis from the ACUITY (acute catheterization and urgent intervention triage strategy) trial.","volume":"54","author":"Prasad","year":"2009","journal-title":"J Am Coll Cardiol"}],"container-title":["Coronary Artery Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MCA.0000000000001030","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,29]],"date-time":"2025-07-29T18:05:03Z","timestamp":1753812303000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MCA.0000000000001030"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3,16]]},"references-count":23,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.1097\/mca.0000000000001030","relation":{},"ISSN":["0954-6928"],"issn-type":[{"value":"0954-6928","type":"print"}],"subject":[],"published":{"date-parts":[[2021,3,16]]}}}